Benzothiazole-Based Polyfunctional Agents in Alzheimer’s Therapy: Dual Diagnostic and Therapeutic Targeting of Aβ, Tau, and Neuroinflammation
The benzothiazole-derived polyfunctional compounds move in a direction that calls for speedy translation research towards the development of disease-modifying agents in AD, and challenges in off-target binding affinity, metabolic instability, Pglycoprotein efflux susceptibility, and the lack of in vivo studies in the l...